RASSF4 and cancer: In oral squamous cell carcinoma (OSCC), the high expression of miR-626 significantly downregulates the RASSF4 expression, thereby activating the Wnt–β-catenin pathway to promote cancer cell proliferation and drive the malignant progression of OSCC through the EMT process [28].